This is a study to determine whether treatment with minocycline is safe and tolerable in
patients with Huntington's disease (HD) and whether minocycline reduces symptoms of HD in
these patients.
Minocycline to Treat Amyotrophic Lateral Sclerosis
Completed
National Institute of Neurological Disorders and Stroke (NINDS)
Phase 3
2003-01-01
The purpose of this trial is to test the safety, tolerability, and effectiveness of
minocycline compared to placebo in patients with amyotrophic lateral sclerosis (ALS).
National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial
Completed
National Institute of Neurological Disorders and Stroke (NINDS)
Phase 2
2003-05-01
The goal of this study is to assess the impact of minocycline and creatine on the progression
of Parkinson's disease, in order to determine whether it is reasonable to proceed with
further study of either of these agents.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
